Most consumers haven't shopped around for standard medical procedures such as a knee replacement, but reference pricing could open that possibility for many services and lower health care costs at the same time.
Jul 15, 2019
0
2
(HealthDay)—A plan to let Medicare patients receive rebates that drug companies currently pay to insurers and middlemen has been withdrawn by the Trump administration.
Jul 12, 2019
0
0
Lawmakers are trying to set aside their irreconcilable differences over the Obama-era Affordable Care Act and work to reach bipartisan agreement on a more immediate health care issue, lowering costs for people who already ...
Jul 7, 2019
1
0
US President Donald Trump on Friday said his administration is working on an executive order to reduce US drug prices to match the lowest in the world.
Jul 6, 2019
1
0
The news is full of stories about monumental surprise hospital bills, sky-high drug prices and patients going bankrupt. The government's approach to addressing this, via an executive order that President Trump signed June ...
Jun 25, 2019
0
0
President Donald Trump will sign an executive order Monday that calls for upfront disclosure by hospitals of actual prices for common tests and procedures to help keep costs down, administration officials said.
Jun 24, 2019
1
0
A large-scale study from The University of Toledo of young African Americans who have attempted or died by suicide suggests there is a greater need for mental health services in urban school districts, and that we need to ...
Jun 24, 2019
0
4
Efforts to control health care costs in the United States often focus on the listed prescription drug prices, but a perspective published by the Journal of the American Medical Association suggests that unregulated pharmacy ...
Jun 21, 2019
0
1
One of the largest studies on out-of-pocket costs for nursing home care finds prices are high and rising faster than other medical care and consumer prices, reports a team of health policy researchers.
Jun 20, 2019
0
0
Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring.
Jun 17, 2019
0
0
